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Abstract
Nonadherence, or not taking medications as prescribed, to antihypertensive medications has been 
associated with uncontrolled hypertension. The authors analyzed data from HealthStyles 2010 to 
assess medication nonadherence among adults with hypertension. The overall prevalence of 
hypertension was 27.4% and the prevalence of nonadherence was 30.5% among hypertensive adult 
respondents. Nonadherence rates were highest among younger adults (aged 18–44 years), 
Hispanics, those who reported lowest annual income (<$25,000), and those who reported 
depression. The most common reason stated for nonadherence was “I cannot afford the 
medication” (35.1%). A multivariate logistic regression model showed age, race, and household 
income to be associated with nonadherence. These findings suggest that certain subgroups are 
more likely to report barriers to adherence. Interventions to support the management of 
hypertension should consider the identification of certain at-risk subgroups and utilize community 
and clinical evidenced-based resources to improve long-term control.
In the United States, nearly one third of adults have hypertension,1 and the estimated 
combined direct and indirect costs of hypertension in 2010 were more than $46.4 billion.2 
The prevalence of awareness among adults with hypertension has increased to nearly 82%.1 
Among those who were aware of their hypertension during 2011–2012, nearly 76% were 
taking antihypertensive medications for blood pressure (BP) control. Of those, 52% had 
controlled hypertension (<140 mm Hg systolic BP and 90 mm Hg diastolic BP).1 While 
awareness and treatment of hypertension has improved in recent years, the percentage of 
patients with controlled hypertension has remained relatively constant.1–3
Despite frequent interactions with the healthcare system and long-standing national 
guidelines for hypertension diagnosis and management, a significant number of diagnosed 
hypertensive adults remained uncontrolled,3 potentially because of the challenges of 
medication adherence.4 Adherence is commonly defined as the extent to which a person’s 
behavior complies with medical advice,5 such as lifestyle modifications or a medication 
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regimen. This paper focuses on adherence to medications specifically; therefore, 
nonadherence in this study was defined as not taking medication as prescribed, missing 
doses for any reason, deliberately skipping doses, believing that one does not need to take 
prescribed medication, or being unable to obtain medication because of cost or other 
barriers. Nonadherence contributes to inadequate BP control, which has been associated 
with increased mortality rates.6 Examples of barriers to medication adherence include failure 
to remember to take medication, cost of medication, lack of health insurance, medication 
side effects, cultural beliefs, patient-physician relationship, depression and other cognitive 
dysfunction (working memory, processing speed), low health literacy, comorbidities, patient 
motivation, coping, financial barriers, and lack of social support.7–12 Sociodemographic 
characteristics were found to be associated with differences in medication adherence. 
Having lower socioeconomic status or being a younger adult, male, or black were associated 
with poor adherence or nonadherence in earlier studies.9,10,13–15 However, few studies have 
explored the rationales behind nonadherence, and only regional information was presented 
in some of the studies.
The Centers for Disease Control and Prevention (CDC) previously reported various barriers 
to medication adherence among adults with hypertension, using the 2005 HealthStyles 
survey.16 Because of significant changes in the US healthcare system, this report provides 
updated information on medication adherence and barriers to adherence.
METHODS
Study Population
The Styles surveys, developed by Porter Novelli, are a series of consumer mail panel surveys 
with data collected by Synovate, Inc. The initial wave, ConsumerStyles, was fielded in April 
through May 2010. Stratified random sampling was used to generate a list of 20,000 
potential respondents who received the ConsumerStyles survey. A total of 10,328 
respondents, including a low-income/minority supplement to ensure adequate representation, 
completed the ConsumerStyles survey. The second survey, HealthStyles, was sent to 6253 
adults aged 18 years and older who completed the ConsumerStyles survey. Responses were 
received from 4198 (67%) adults. CDC aided with the questionnaire design, and all data 
were weighted by age, sex, race/ethnicity, income, and household size to replicate 
proportions in the 2009 Current Population Survey (http://www.census.gov/cps). Data were 
self-reported and were provided in aggregate to the CDC.
Definition of Study Measurements
Respondents were chosen for our study if they answered “yes” to the question, “Are you 
currently taking prescribed medication for your high blood pressure?” Respondents were 
classified as nonadherent in taking antihypertensive medication if they chose any of the 12 
answers listed in question 1: “What are the reasons that you are not taking your blood 
pressure medication exactly as prescribed?” (Table I) More than one barrier could be 
reported. The perceived rationales for the reported barrier, “I do not think I need to control 
my blood pressure,” were explored using a series of responses related to behavioral changes 
or perceptions of need (Table I).
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In the current study, data from HealthStyles and ConsumerStyles were linked to obtain 
descriptive information and health behaviors. The descriptive variables included sex, age, 
race/ethnicity, education, and income. The chronic health conditions included diabetes, 
congestive heart failure, atrial fibrillation, high cholesterol, cancer (except skin), depression, 
and migraines. Other risk factors included current smoking status, body mass index (divided 
into three categories: underweight/normal weight [<25.0 kg/m2], overweight [25.0–29.9 
kg/m2], and obese [≥30 kg/m2]), and number of prescription medication(s) taken daily. The 
health behavior variables were (1) number of primary care visits, (2) time of last BP check, 
and (3) use of a monitor to check BP at home.
Data Analysis
Univariate associations were examined by selected characteristics for outcomes of 
nonadherence using the chi-square or Fisher exact test, as appropriate. Univariate and 
multivariate logistic regression analysis were performed independently to further examine 
the association of nonadherence with the selected independent variables listed above. Both 
unadjusted odds ratios (ORs) and adjusted ORs (AORs) were estimated, along with 95% 
confidence intervals (CIs). The two-tailed P values at level .05 were considered significant. 
All statistical analyses were performed with the statistical software package SAS 9.3 (SAS 
Institute, Inc, Cary, NC).
RESULTS
Among 4198 adult respondents, 1366 (27.4%) had self-reported hypertension, and 1180 
(23.3%) reported that they were currently taking medication for hypertension. Among the 
hypertensive adults, 329 (30.5%) reported barriers to taking their antihypertensive 
medications and were, therefore, classified as nonadherent. Table II describes the 
distribution of the selected characteristics among this population by nonadherence. The 
percentage of nonadherence did not differ by sex or education level, but did differ by age 
(from 45.3% aged 18–44 years to 22.1% aged ≥65 years, P=.0009), race/ethnicity (25.4% in 
whites, 38.4% in blacks, 47.0% in Hispanics; P=.009) and household income (from 41.4% 
with income <$25,000 to 24.5% with income ≥$60,000, P=.009). Hypertensive adults with 
depression reported greater nonadherence than those without depression (37.8% vs 26.8%, 
respectively; P=.02). There were no significant differences in health behaviors between 
nonadherent and adherent hypertensive adults.
Among all the reported reasons for not taking BP medication exactly as prescribed, “I 
cannot afford the medication” was the most common (35.1%), followed by “I do not think I 
need it to control my blood pressure” (27.1%) and “I forgot to take the medication” (23.6%) 
(Figure 1). Fewer than 1% of hypertensive adults reported the reasons, “I share the 
medication with someone else” and “The medication is not working.” No respondent 
selected the response, “I do not know how to take medication.” The majority (74.3%) of 
nonadherent hypertensives provided a single response to the question of adherence.
Among all the reported rationales for thinking that medications were not needed to control 
BP, the most commonly reported reasons were “I’m cutting down on salt” (53.1%), followed 
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by “I’m changing my eating habits” (42.4%), “I’m trying to lose weight/I have lost weight” 
(41.7%), and “I’m exercising more” (39.2%) (Figure 2).
We further looked at the demographic features among the respondents who reported the 
most common reasons for not taking antihypertensives exactly as prescribed. The percentage 
of nonadherent hypertensives aged 18 to 44 years (49.3%) who reported “I cannot afford the 
medication” was significantly greater than the percentages of those aged 45 to 64 years 
(32.6%) and 65 years and older (20.4%; P=.02) (Table III). The percentage of the non-
Hispanic other race/ethnicity group who reported “I do not think I need it to control my 
blood pressure” (61.9%) was significantly greater than the percentages of non-Hispanic 
whites (20.3%) and non-Hispanic blacks (15.7%; P=.02). The percentage of those with a 
household income <$25,000 who reported “I cannot afford the medication” (48.6%) was 
significantly greater than the percentages of those with a household income $25,000 to 
$59,999 (31.4%) and ≥$60,000 (20.5%; P=.02). However, the percentage of those with a 
household income <$25,000 who reported “I forgot to take the medication” (14.2%) was 
significantly lower than the percentages of those with a household income $25,000 to 
$59,999 (30.1%) and ≥$60,000 (29.9%; P=.02).
Finally, we examined the factors associated with nonadherence by using both univariate and 
multiple logistic regression. Age, race, and household income were significantly associated 
with nonadherence (Table IV). The results from multivariate analysis showed adults aged 18 
to 44 years (AOR, 3.33; 95% CI, 1.78–6.23) and aged 45 to 64 years (AOR, 1.53; 95% CI, 
1.05–2.22) were more likely to be nonadherent than were those aged 65 years and older. 
Hispanics were significantly more likely to be nonadherent than non-Hispanic whites (AOR, 
2.13; 95% CI, 1.20–3.77). The adults who reported a household income of <$25,000 were 
twice as likely to be nonadherent as were those reporting ≥$60,000 (AOR, 1.92; 95% CI, 
1.20–3.08).
DISCUSSION
In our study of hypertensive US adults, the overall self-reported nonadherence percentage 
was 30.5%. Age, race/ethnicity, and income were significant factors associated with 
nonadherence to prescribed antihypertensive medications. The top three most commonly 
reported barriers or reasons (cannot afford, don’t need, and forgot) for nonadherence were 
also associated with age, race, and household income. Furthermore, the reported rationales 
for nonadherence among those who did not think they should control their BP were “I’m 
cutting down on salt,” “I’m changing my eating habits,” and “I’m trying to lose weight/I 
have lost weight.”
Younger adults, Hispanics, and those with the lowest income were more likely to be 
nonadherent compared with their counterparts. Prior reports have demonstrated associations 
between nonadherence and demographic factors such as age, race, and income.7–12,14 A 
potential mechanism proposed by the health belief model17 relates adherence to age, 
suggesting that the oldest group of adults, often having greater severity of disease(s), are 
more motivated to adhere to taking their prescribed medications.17 Older adults may also be 
more likely to receive support from caregivers at home to aid in their medication 
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adherence.18 In addition, better insurance coverage, such as Medicare Part D for those aged 
65 years and older,19 is a plausible explanation for higher adherence. In our study, the 
association between nonadherence and age not only persisted but showed that younger 
adults (aged 18–44 years) were three times as likely to be nonadherent, after controlling for 
race/ethnicity, income, and depression. However, there are few new intervention strategies 
specifically targeting younger hypertensives, underscoring the need for further research.18
In the current study, Hispanic respondents were more likely to be classified as nonadherent 
than were non-Hispanic blacks or whites. This outcome is consistent with previous studies 
finding that Hispanics have the highest percentage of uncontrolled hypertension, largely 
attributed to nonadherence.20,21 In our study, more than half of hypertensive Hispanics 
reported that they did not need to control their BP. A number of potential factors have been 
reported that could explain these findings, including language barriers, cultural beliefs, a 
lack of health insurance or a usual source of care, lower income, lower baseline health 
literacy, and younger age distribution.21,22 The Institute of Medicine recommends that 
community health workers (also known as health promoters or promotores de salud) be part 
of comprehensive multidisciplinary teams as a strategy for improving care delivery, 
implementing secondary prevention strategies, and enhancing risk reduction.23 Interventions 
designed specifically for Hispanics, such as Health for Your Heart (Salud Para Su Corazon) 
and Community Health Workers for Hypertension Control (Salud Contra la Hipertensión), 
use health promoters to address issues of socioeconomic status and healthcare access related 
to hypertension management. Such interventions can reduce cultural, language, and access 
barriers to adherence and improve hypertension control.24,25
Our findings, consistent with results from previous studies,10,16 also demonstrated that those 
with the lowest reported household income were more nonadherent than were those in 
higher-income categories. Other studies19,26 have recommended strategies for reducing cost 
barriers, including once-daily dosing of low-cost medications, 90-day prescription fills, and 
expansion of health insurance coverage.
A previous report showed a statistically significant association between mental health—
including the diagnosis of depression, migraines, and/or anxiety—and nonadherence.16 
Several studies have indicated a significant association between depression and 
nonadherence.27–30 Our study focused solely on the association between self-reported 
depression and nonadherence. Depression was associated with nonadherence in univariate 
analysis but the relationship was not statistically significant in our multivariate analysis. The 
marginal significance on depression obtained in the multivariate analysis might indicate a 
lack of power because of the small sample size. It would be worthwhile to examine this 
relationship in future appropriately powered studies and to provide interventions for the 
management of hypertension among populations with mental health issues.
The most prevalent of the commonly reported barriers to adherence was cost, which is likely 
correlated with household income. Numerous studies have emphasized cost as a significant 
barrier to medication adherence.10,31 One report demonstrated that a comprehensive 
hypertension management program that included education and no-cost medication was 
associated with significant improvements in hypertension control during the 6-month study 
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period.32 Likewise, another report showed that lower yearly income was associated with 
nonadherence.16 The Institute of Medicine recommends partnering with the business 
community to help reduce the costs of antihypertensive medications in order to improve 
adherence.31 Furthermore, implementation of the Affordable Care Act (ACA) may help 
waive cost-sharing (the portion of healthcare costs paid by the patient) for preventive 
services and increase prescription-drug coverage.33 Because the ACA was implemented 
after our study, it would be interesting for future studies to observe how the ACA has 
affected medication adherence.19
The second most commonly reported barrier was the belief that one did not need to take the 
medication. The most frequent rationales observed in our study were “I’m cutting down on 
salt” (53.1%), “I’m changing my eating habits” (42.4%), “I’m trying to lose weight/I have 
lost weight” (41.7%), and “I’m exercising more” (39.2%). These rationales might be related 
to the misconception that substituting lifestyle changes is the best or only modality for 
hypertension control and to a lack of understanding about the importance and effectiveness 
of antihypertensive therapy. To address this knowledge gap, some researchers have 
recommended the use of motivational interviewing by healthcare providers to gain a better 
perspective on their patients’ understanding of their health or health beliefs, which, in turn, 
could help patients use medications better.34,35 Hypertension management protocols should 
also take these factors into consideration, even as healthcare providers continue to 
individualize care to improve adherence among hypertensive adults and prevent the 
development of serious negative consequences of hypertension such as heart attack, 
congestive heart failure, stroke, and chronic kidney disease. Our findings provide 
meaningful insight for healthcare providers to understand different aspects of 
antihypertensive medication nonadherence among hypertensive adults. Findings from this 
study could be used by clinicians and public health practitioners when developing 
interventions for increasing adherence or when providing education and counseling to 
clarify that starting medications is required in addition to continuing lifestyle modifications.
The third most commonly reported barrier to adherence, also supported by previous 
findings, was forgetting to take antihypertensive medications.36,37 Findings from several 
studies support the use of various intervention strategies that have improved adherence by 
addressing this issue. These strategies include home visits, education, special dosing 
devices, small group training, telephone reminders, simplification of dosing regimen (one 
dose per day when possible), and 90-day prescriptions and counseling,38,39 alone or in 
combination. In fact, several studies have supported the efficacy of a combined approach. A 
recent study showed multifactorial interventions where the healthcare provider counted 
patients’ pills, designated a family member to support adherence, and provided education to 
patients were more effective than simple mailing or educational efforts.40 In addition, 
another study showed that pharmacists in face-to-face settings and nurses at hospital 
discharge were more effective in intervening and improving adherence.41
STUDY LIMITATIONS
Limitations to our study include the response rate of 67.1% to the HealthStyles mail survey, 
which might lead to nonresponse bias. Although the HealthStyles survey is a population 
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survey designed to match the characteristics of the US adult population, survey participants 
volunteered to participate and were not a random sample; thus, our findings are subject to 
selection bias. In addition, the survey requires literacy in the English language and a mailing 
address, which excludes some households from participation. The survey questions 
pertaining to barriers to adherence, although covering a broad range of factors, may still 
have missed some important reasons for nonadherence. Lastly, because of the self-reported 
nature of the survey, recall bias or underreporting or overreporting attributable to social 
desirability is likely and could affect estimates of nonadherence.
CONCLUSIONS
Our study found that overall nonadherence was 30.5% and was more prevalent among 
younger adults, Hispanics, and those with lower income. Affordability was the top reason 
reported for nonadherence. Promoting public health and health policy interventions might be 
needed to minimize the cost of medications. Our study also identified the need for clinicians 
to explore patients’ rationales and perceptions regarding their hypertension medications, and 
reinforced the importance of consistent medication use to control hypertension. 
Interventions that support the management of hypertension, particularly in at-risk 
populations, and that use community-based and clinical evidenced-based resources to 
improve medication adherence should be considered.
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Reasons nonadherent hypertensive adults reported not taking blood pressure medications—
HealthStyles Survey, 2010.
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Rationales nonadherent hypertensive adults reported nonadherence—HealthStyles Survey, 
2010.
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TABLE I
HealthStyles 2010 Survey Questions and Response Choices for the Ascertainment of Nonadherence in 
Respondents
Question 1: What are the reasons that you are not taking your 
blood pressure medication exactly as prescribed? (Check all that 
apply)
Question 2: If you don’t think you need your prescribed 
medication to control your blood pressure, why not? (Check all 
that apply)
Answers Answers
1 I forgot to take my medication.
2 I don’t like the side effects from the 
medication.
3 I share the medication with someone else.
4 I do not think I need it to control my blood 
pressure.
5 I think I should be taking a different 
medication.
6 I do not know how to take the medication.
7 I cannot afford the medication.
8 The medication is not working.
9 I feel okay without medication.
10 I ran out of medication.
11 Other reason.
12 Don’t know.
1 My blood pressure is now controlled so I do 
not need it.
2 I’m taking something else (eg, herbal 
supplement, natural remedy).
3 I’m using an alternative therapy (eg, 
acupuncture, tai chi, massage).
4 I’m trying to lose weight/I have lost weight.
5 I’m changing my eating habits.
6 I do not know how to take the medication.
7 I’m cutting down on salt.
8 I’m reducing alcohol.
9 I’m exercising more.
10 I have quit smoking.
11 Other reason.
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TABLE II
Percentage of Respondents Reporting Nonadherence in Taking High BP Medication, by Selected 
Characteristics—HealthStyles Survey, 2010
Nonadherence in Taking BP Medication
Characteristic No. (%) No. % (95% CI) P Valuea
Overall 1180 329 30.5 (26.7–34.3)
Demographics
 Age, y
  18–44 132 (22.4) 54 45.3 (32.7–57.9) .0009
  45–64 576 (43.0) 171 29.6 (25.5–33.8)
  ≥65 472 (34.7) 104 22.1 (18.0–26.2)
 Sex
  Male 650 (53.8) 180 29.7 (24.7–34.8) .66
  Female 530 (46.2) 149 31.4 (25.7–37.2)
 Race
  Non-Hispanic white 810 (68.5) 193 25.4 (21.5–29.2) .009
  Non-Hispanic black 162 (14.1) 59 38.4 (27.2–49.6)
  Hispanic 113 (11.5) 44 47.0 (32.9–61.1)
  Non-Hispanic other 95 (5.9) 33 39.7 (23.0–56.4)
 Household income, in $1000s
  <25 345 (30.0) 127 41.4 (33.5–49.3) .009
  25–39.9 151 (16.4) 38 28.8 (18.1–39.4)
  40–59.9 176 (15.4) 45 26.2 (18.8–33.6)
  ≥60 508 (38.1) 119 24.5 (19.6–29.3)
 Education level (n=1174)
  High school graduate or less 381 (31.1) 117 33.2 (27.0–39.4) .33
  Some college 428 (39.3) 121 31.1 (24.0–38.2)
  College graduate or more 365 (29.6) 89 26.8 (20.9–32.7)
Health status
 Current smoker (n=1139)
  Yes 176 (17.4) 58 38.9 (26.8–51.1) .13
  No 963 (82.6) 255 28.4 (24.7–32.2)
 BMI (n=1153)
  <25 211 (18.9) 60 32.6 (23.3–41.9) .44
  25–30 384 (31.4) 96 26.6 (19.5–33.7)
  ≥30 558 (49.7) 162 31.8 (26.5–37.2)
 Diabetes
  Yes 315 (26.7) 86 31.7 (24.5–38.9) .72
  No 865 (73.3) 243 30.1 (25.6–34.6)
 High cholesterol
  Yes 581 (48.9) 175 32.4 (27.3–37.5) .35
  No 599 (51.1) 154 28.7 (23.0–34.5)
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Nonadherence in Taking BP Medication
Characteristic No. (%) No. % (95% CI) P Valuea
 Congestive heart failure
  Yes 55 (4.9) 18 48.8 (29.6–67.9) .12
  No 1125 (95.1) 311 29.6 (25.8–33.4)
 Any cancer (except skin)
  Yes 46 (4.0) 13 32.0 (15.6–48.4) .86
  No 1134 (96.0) 316 30.5 (26.6–34.4)
 Migraines
  Yes 116 (11.4) 42 42.2 (29.9–54.5) .06
  No 1064 (88.6) 287 29.0 (25.1–33.0)
 Depression (n=971)
  Yes 285 (29.6) 99 37.8 (30.5–45.1) .02
  No 686 (70.4) 157 26.8 (21.4–32.1)
Number of medications taken (n=1160)
  One 615 (54.4) 172 29.0 (23.6–34.4) .35
  Two 330 (26.9) 81 27.3 (21.2–33.4)
  More than two or combination drug 215 (18.7) 64 35.9 (26.5–45.3)
Health behaviors
 Number of primary care provider visits in the past year
  0 66 (7.5) 28 50.6 (29.9–71.3) .10
  1–3 649 (53.7) 168 26.9 (22.2–31.6)
  4 or more 465 (38.9) 133 31.7 (26.0–37.3)
 Time of last BP check (n=1166)
  Within past 6 months 1067 (90.6) 288 29.6 (25.7–33.5) .32
  More than 6 months earlier 99 (9.4) 35 38.0 (22.5–53.5)
 Using BP monitor to check BP at home (n=1085)
  Yes 598 (52.8) 157 29.2 (24.0–34.3) .80
  No 487 (47.2) 143 30.1 (24.8–35.5)
Abbreviations: BMI, body mass index; BP, blood pressure; CI, confidence interval.
a
From chi-square test to estimate the significant differences within each selected characteristic.
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TABLE IV
Univariate and Multivariate Logistic Regression on Nonadherence in Taking High Antihypertensive 
Medications, by Selected Characteristics—HealthStyles, 2010
Characteristic Unadjusted Odds Ratio (95% CI) Adjusted Odds Ratio (95% CI)
Age, y
 18–44 2.92 (1.67–5.11) 3.33 (1.78–6.23)
 45–64 1.49 (1.09–2.02) 1.53 (1.05–2.22)
 ≥65 Reference Reference
Sex
 Male Reference Reference
 Female 0.92 (0.64–1.32) 1.00 (0.67–1.49)
Race
 Non-Hispanic whites Reference Reference
 Non-Hispanic black 1.84 (1.10–3.07) 1.71 (0.97–3.01)
 Hispanic 2.61 (1.43–4.77) 2.13 (1.20–3.77)
 Non-Hispanic other 1.94 (0.94–4.01) 1.44 (0.60–3.47)
Household income, in $1000s
 <25 2.18 (1.44–3.32) 1.92 (1.20, 3.08)
 25–59.9 1.17 (0.77–1.79) 1.09 (0.68–1.75)
 ≥60 Reference Reference
Depression
 Yes 1.66 (1.10–2.51) 1.33 (0.87–2.03)
 No Reference Reference
Abbreviation: CI, confidence interval.
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